TH Announces Agreement with AIDS DRUG ASSITANCE PROGRAM (ADAP) for TROGARZO™ and EGRIFTA®
TH Announces Agreement with AIDS DRUG ASSITANCE PROGRAM (ADAP) for TROGARZO™ and EGRIFTA®
May 23, 2018
Supporting Materials:
Theratechnologies Inc. (TSX: TH) is pleased to announce that it has reached a pricing agreement with the AIDS Drug Assistance Program Crisis Task Force. The agreement opens access to TrogarzoTM (ibalizumabuiyk) injection and EGRIFTA® (tesamorelin for injection) to low income, underinsured and uninsured Americans in all 50 states and the territories.